Clinical trial
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
NCT00006392 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00006392 |
|---|---|
| Title | S0000 Selenium and Vitamin E in Preventing Prostate Cancer |
| Official title | Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer |
| Acronym | SELECT |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group Cancer and Leukemia Group B NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Other |
| Interventions | Vitamin E, Selenium, Vitamin E placebo, selenium placebo |
| Enrollment | 35,533 |
| Start date | Jul 1, 2001 |
| Primary completion | May 1, 2011 |
| Completion | Sep 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 20, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: